Results 1 to 10 of about 4,963 (151)
Cancer Medicine, 2023 Background Cross‐lineage expression of the myeloid‐associated antigens CD13/CD33 is common in adult B‐lymphoblastic leukemia (B‐ALL) patients, yet its prognostic value is still controversial.
Hongyan Liao, Jiao Chen, Xiao Shuai
exaly +4 more sources
CD13 is a bona-fide marker of bovine pre-adipocytes with potential in cultivated fat applications [PDF]
npj Science of FoodDespite its significant potential, cultivated fat manufacture remains a relatively inefficient process, as it primarily uses source preparations of animal-derived mesenchymal stem/stromal cells (MSC) that are poorly defined and highly heterogenous in ...
Seungmee Lee +4 more
doaj +2 more sources
Immunophenotypic Aberrancies in Acute Leukemia: A Tertiary Care Centre Experience
Oman Medical Journal, 2021 Objectives: Acute leukemias (AL) are a heterogeneous group of hematological malignancies with the presence of 20% or more blasts in the peripheral blood or bone marrow.
Monika Gupta +5 more
doaj +1 more source
Characterization of CD13 and CD33 Surface Antigen–Negative Acute Myeloid Leukemia [PDF]
American Journal of Clinical Pathology, 2000 From a cohort of 220 adults with newly diagnosed acute myeloid leukemia (AML), 8 (3.6%) exhibited a rare variant of aberrant membrane phenotype. It was characterized with typical myeloid morphologic and cytochemical patterns and absence of myeloid associated antigens (CD13, CD33, CD14, glycophorin A, CD61).
N, Kraguljac +8 more
openaire +2 more sources
Myeloid Antigen, CD13, CD14, and/or CD33 Expression Is Restricted to Certain Lymphoid Neoplasms [PDF]
American Journal of Clinical Pathology, 1996 The authors examined the expression of myeloid antigens (MyAg): CD11b, CD13, CD14, CD15, and CD33 in 249 adults with lymphoid neoplasms using flow cytometric analysis. In this study, acute leukemia that was myeloperoxidase negative by light microscopy and had at least one lymphoid antigen was defined as acute lymphoblastic leukemia (ALL).
K, Nakase +8 more
openaire +2 more sources
Indian Journal of Health Sciences and Biomedical Research KLEU, 2022 BACKGROUND: The identification of aberrant phenotypes in acute leukemia is crucial for treatment monitoring and minimal residual disease analysis.
Sana Ahuja, Avneesh Malviya
doaj +1 more source
Frontiers in Immunology, 2023 Oral subunit vaccines are an interesting alternative strategy to traditional live-attenuated or inactivated vaccines for conferring protection against gut pathogens.
Hans Van der Weken +4 more
doaj +1 more source
The Expression of Myeloid Antigens CD13 and/or CD33 Is a Marker of ALK+ Anaplastic Large Cell Lymphomas [PDF]
American Journal of Clinical Pathology, 2008 We retrospectively studied the immunophenotype by flow cytometry of 20 anaplastic large cell lymphomas (ALCLs) (9 anaplastic lymphoma kinase [ALK]+ and 11 ALK-) with a particular emphasis on the aberrant expression of the myeloid associated antigens CD13 and/or CD33. All ALCLs expressed CD45, HLA-DR, and CD30. Most (8/9) ALK+ ALCLs expressed at least 1
Ian M, Bovio, Robert W, Allan
openaire +2 more sources
Evaluation of aberrant expression of CD markers in acute leukemia cells
Zanco Journal of Medical Sciences, 2023 Background and objective: Worldwide immunophenotyping by flow cytometry (FCM) in acute leukemia (AL) is the golden step in the diagnosis. It’s very common for acute leukemias to aberrantly express antigens or cluster of differentiation (CD) markers which
Lava kareem Shwani +2 more
doaj +1 more source
Multiple gastric involvement by myeloid antigen CD13‐positive non‐secretory plasma cell leukaemia [PDF]
British Journal of Haematology, 1996 Gastrointestinal tract involvement is a rare complication of plasma cell neoplasia. We present a case of non‐secretory type primary plasma cell leukaemia (PCL) with multiple gastric involvement. Dual surface antigen analysis of bone marrow cells revealed that atypical plasma cells coexpressed CD38 and myeloid antigen CD13.
A, Ohsaka +6 more
openaire +2 more sources